Vicodin vex: DEA tightens restrictions on hydrocodone combos

From NeurologyWire

On Friday the US Drug Enforcement Administration (DEA) will move hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II.Pure hydrocodone drugs have been listed as Schedule II drugs since the creation of the list in 1971. But hydrocodone-combination products (HCPs)those made with specified amounts of other ther...

Login to read story

Monday, August 11, 2014

Show last days of articles

New upper extremity standard biopsy sites for diagnosis of s...

From NeurologyWire

Therapath LLC "has established normative values for two upper limb body sites that can now be used to evaluate 3mm punch skin biopsy specimens for Epi...Full story

Infectious prion protein discovered in urine of patients wit...

From NeurologyWire

The misfolded and infectious prion protein that is a marker for variant Creutzfeldt-Jakob disease linked to the consumption of infected cattle meat ...Full story

Friday, August 08, 2014

HIV Infection Linked to Lower Risk of MS

From NeurologyWire

New research shows HIV infection is associated with a significantly decreased risk of developing MS. Mechanisms of this observed possibly protective a...Full story

Novel biomarker predicts febrile seizure-related epilepsy, s...

From NeurologyWire

A newly discovered biomarker visible in brain scans for hours after febrile seizures predicts which individuals will subsequently develop epilepsy, ...Full story

Thursday, August 07, 2014

Dental device FDA approved for sleep apnea

From NeurologyWire

MicroDental Laboratories says the FDA has cleared the company's MicrO2 Obstructive Sleep Apnea Device. The first CAD/CAM milled Obstructive Sleep Apne...Full story

Link Between Vitamin D and Dementia Risk Confirmed

From NeurologyWire

In the largest study of its kind, researchers suggests that in older people, not getting enough vitamin D may double the risk of developing dementia a...Full story

Wednesday, August 06, 2014

High mortality after early stroke

From NeurologyWire

Nearly one in six teens and adults who initially survive a stroke before age 50 die over the next decade, according to a new study.At the end of follo...Full story

Tuesday, August 05, 2014

Frailty and dementia: What is the link?

From NeurologyWire

What is the relationship between frailty and dementia? Many studies acknowledge that frailty and dementia often coexist, but little research has been ...Full story

Monday, August 04, 2014

Dementia 'more feared than cancer'

From NeurologyWire

Older people are more fearful of developing dementia than they are of cancer, a new poll from the UK suggests.Two thirds of people over the age of 50 ...Full story

Wednesday, July 30, 2014

FDA approves new oxycodone with abuse-deterrent properties

From NeurologyWire

On July 23 the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), a...Full story

Neuro researchers advocate for a shift in thinking for strok...

From NeurologyWire

With the advent of non-surgical modalities, stimulation of the brain has become a popular science and researchers must work to ensure systematic metho...Full story

RapidArc Radiosurgery More Efficient and Comparable in Quali...

From NeurologyWire

RapidArc Radiosurgery can be used to deliver treatments for multiple brain metastases that are substantially less time consuming and comparable in qua...Full story

Monday, July 28, 2014

NIH scientists find six new genetic risk factors for Parkins...

From NeurologyWire

Using data from over 18,000 patients, scientists have identified more than two dozen genetic risk factors involved in Parkinsons disease, including si...Full story

Friday, July 25, 2014

CDC Takes Inside Look at ALS

From NeurologyWire

The firstand to date the onlyeffort to estimate the national prevalence of amyotrophic lateral sclerosis in the United States has concluded, unsurpris...Full story

MS drug Plegridy receives European marketing approval

From NeurologyWire

The European Commission (EC) has granted marketing authorisation for Biogen Idec.'s Plegridy (peginterferon beta-1a) as a treatment for adults with re...Full story